Cartesian Therapeutics, Inc. (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

6.07

-0.53 (-8.03%)

At close: Mar 24, 2026, 4:00 PM EDT

6.05

-0.02 (-0.30%)

After-hours: Mar 24, 2026, 6:53 PM EDT

Cartesian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	125.14	212.61	76.91	106.44	114.06
Short-Term Investments	-	-	-	28.16	14
Cash & Short-Term Investments	125.14	212.61	76.91	134.6	128.06
Cash Growth	-41.14%	176.44%	-42.86%	5.11%	-7.66%
Accounts Receivable	1.12	0.87	5.87	6.6	9.91
Other Receivables	-	-	2.98	3.16	-
Total Trade Receivables	1.12	0.87	8.85	9.76	9.91
Other Current Assets	3.02	3.14	4.97	3.78	6.47
Total Current Assets	129.28	216.63	90.73	148.14	144.44
Net Property, Plant & Equipment	17.79	15.45	12.18	14.41	11.97
Other Intangible Assets	93.9	150.6	150.6	-	-
Goodwill	48.16	48.16	48.16	-	-
Long-Term Investments	-	2	2	2	2
Other Long-Term Assets	7.29	2.19	1.38	1.34	1.47
Total Assets	296.41	435.02	305.05	165.89	159.88
Accounts Payable	1.29	0.29	3.15	0.32	0.22
Accrued Expenses	9.5	12.08	15.57	14.08	10.53
Short-Term Debt	-	-	-	8.48	5.96
Current Portion of Leases	4.15	2.85	2.17	1.61	-
Unearned Revenue	-	-	2.31	0.59	53.88
Other Current Liabilities	-	7.76	45.01	-	-
Total Current Liabilities	14.94	22.98	68.21	25.08	72.25
Long-Term Debt	-	-	-	17.79	19.67
Long-Term Leases	8.53	11.13	8.79	10.06	8.6
Other Long-Term Liabilities	399.19	407.72	367.68	19.14	36.84
Total Long-Term Liabilities	407.71	418.85	376.47	46.98	65.11
Total Liabilities	422.65	441.83	444.68	72.06	137.36
Common Stock	0	0	0	0	0.01
Additional Paid-in Capital	700.71	689.89	179.06	493.31	457.39
Accumulated Other Comprehensive Income	-4.58	-4.62	-4.6	-4.56	-4.57
Retained Earnings	-822.37	-692.07	-614.65	-394.94	-430.32
Total Common Shareholders' Equity	-126.24	-6.8	-440.18	93.83	22.52
Minority Interest	-	-	300.55	-	-
Shareholders' Equity	696.13	685.27	-139.63	93.81	22.52
Total Liabilities & Equity	296.41	435.02	305.05	165.89	159.88
Total Debt	12.68	13.98	10.96	37.93	34.23
Net Cash (Debt)	112.46	198.63	65.96	96.68	93.82
Net Cash Growth	-43.38%	201.15%	-31.78%	3.04%	-10.00%
Net Cash Per Share	4.33	11.44	12.76	0.66	0.82
Book Value	-126.24	-6.8	-440.18	93.83	22.52
Book Value Per Share	-4.86	-0.39	-85.14	0.64	0.20
Tangible Book Value	-268.3	-205.57	-638.95	93.83	22.52
Tangible Book Value Per Share	-10.33	-11.84	-123.58	0.64	0.20

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q